As of Mar 16
| -1.50 / -4.54%|
The 7 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 44.00, with a high estimate of 56.00 and a low estimate of 34.00. The median estimate represents a +39.64% increase from the last price of 31.51.
The current consensus among 8 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.